Journal
FEBS LETTERS
Volume 585, Issue 2, Pages 402-408Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2010.12.027
Keywords
Leukaemia; miR-21; Daunorubicin; Drug resistance; PTEN; PI3K/Akt
Funding
- National Natural Science Foundation of China [81070135]
Ask authors/readers for more resources
Recent studies have shown microRNA-21 (miR-21) is overexpressed in several types of cancer and contributes to tumor resistance to chemotherapy. In this study, we investigated whether miR-21 mediated resistance of the leukaemia cell line K562 to the chemotherapeutic agent daunorubicin (DNR). miR-21 expression was upregulated in the DNR resistant cell line K562/DNR compared to its parental line K562. Stable transfection of miR-21 induced drug resistance in K562, while suppression of miR-21 in K562/DNR led to enhanced DNR cytotoxicity. Additional experiments indicate that the mechanism of miR-21 drug resistance involves the PI3K/Akt pathway and changes following PTEN protein expression. This study provides a novel mechanism for understanding leukaemia drug resistance. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available